Unique ID issued by UMIN | UMIN000009264 |
---|---|
Receipt number | R000010866 |
Scientific Title | The evaluation of symptom and pathophysiological changes after 20mg of esomeprazole administration by 24-hour intraesophageal pH/impedance (MII-pH) monitoring. |
Date of disclosure of the study information | 2012/11/10 |
Last modified on | 2019/11/11 09:13:24 |
The evaluation of symptom and pathophysiological changes after 20mg of esomeprazole administration by 24-hour intraesophageal pH/impedance (MII-pH) monitoring.
The evaluation of symptom and pathophysiological changes after esomeprazole administration by impedance monitoring.
The evaluation of symptom and pathophysiological changes after 20mg of esomeprazole administration by 24-hour intraesophageal pH/impedance (MII-pH) monitoring.
The evaluation of symptom and pathophysiological changes after esomeprazole administration by impedance monitoring.
Japan |
PPI-resistant gastro-esophageal reflux disease
Medicine in general | Gastroenterology |
Others
YES
To evaluate the symptom and pathophysiological changes by esomeprazole, PPI-resistant GERD patients are administrated esmeprazole instead of other PPIs and evaluate the symptom and pathophysiological changes.
Safety,Efficacy
Confirmatory
Explanatory
Not applicable
symptom, QOL, neurosis evaluation by questionnaire
pathophysiology of GERD by 24-hour intraesophageal pH/impedance monitoring, HP infection, gastric mucosal atropy, CYP2C19 genetic polymorphism
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Treatment
Medicine |
The subjects take 20 mg of esomeprazole once a day for four weeks.
20 | years-old | <= |
Not applicable |
Male and Female
(1) The study is conducted with the written informed consent of patients who had been given a full explanation of the study.
(2)The GERD patients who has taken standard dose PPIs for 8 weeks.
(3)The patients who was judged to be insufficient therapeutic response by GerdQ questionnaire.
(1)alarm sign such as vomitting or gastrointestinal bleeding
(2)Zollinger Ellison syndrome, esophageal stenosis, achalasia, cerebrovascular disorder
(3)Serious hepatic disorder, renal disease, heart disorder
(4)malignant disorder
(5)A pregnant woman, nursing mother or the woman who may be pregnant.
(6)In addition, clinical studies supervisor or the study attending physician judged the subject to be inadequate to attend this study.
40
1st name | Kunio |
Middle name | |
Last name | Kasugai |
Aichi Medical University School of Medicine
Gastroenterology
480-1195
1-1 Yazakokarimata, Nagakute, Aichi, 480-1195, Japan
0561-62-3311
kuku3487@aichi-med-u.ac.jp
1st name | Kunio |
Middle name | |
Last name | Kasugai |
Aichi Medical University School of Medicine
Gastroenterology
480-1195
1-1 Yazakokarimata, Nagakute, Aichi, 480-1195, Japan
0561-62-3311
kuku3487@aichi-med-u.ac.jp
Division of Gastroenterology, Aichi Medical University School of Medicine
Research Organization for GastroEnterological Disease Treatment
Non profit foundation
Japan
non
non
Aichi Medical University School of Medicine
1-1 Yazakokarimata, Nagakute, Aichi, 480-1195, Japan
0561-62-3311
syomu@aichi-med-u.ac.jp
NO
愛知医科大学病院(愛知県)
2012 | Year | 11 | Month | 10 | Day |
Unpublished
Completed
2012 | Year | 05 | Month | 01 | Day |
2012 | Year | 05 | Month | 30 | Day |
2012 | Year | 05 | Month | 30 | Day |
2016 | Year | 04 | Month | 30 | Day |
2016 | Year | 05 | Month | 31 | Day |
2016 | Year | 08 | Month | 31 | Day |
2016 | Year | 10 | Month | 30 | Day |
2012 | Year | 11 | Month | 05 | Day |
2019 | Year | 11 | Month | 11 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000010866